English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1983]
News [3212]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
HPV vaccine 'could substantially reduce' cervical cancer incidence
HPV vaccine 'could substantially reduce' cervical cancer incidence
NCRI Cancer Conference, Liverpool, Wednesday 9 November 2011
NCRI Cancer Conference, Liverpool, Wednesday 9 November 2011
Researchers find a way to screen for broad range of cancer-causing genetic changes as part of routine clinical practice, bringing effective personalised medicine a step closer
Researchers find a way to screen for broad range of cancer-causing genetic changes as part of routine clinical...
Studies reveal potential of HPV vaccine to substantially reduce incidence of cervical cancer and suggest screening programmes could be modified
Studies reveal potential of HPV vaccine to substantially reduce incidence of cervical cancer and suggest screening...
NCRI Cancer Conference, Liverpool, Tuesday 8 November 2011
NCRI Cancer Conference, Liverpool, Tuesday 8 November 2011
Annual cardioncology meeting integrates cardiology and oncology research
Annual cardioncology meeting integrates cardiology and oncology research
NCRI 2011: First evidence of new druggable DNA repair target to destroy cancer cells
NCRI 2011: First evidence of new druggable DNA repair target to destroy cancer cells
New druggable DNA repair target to destroy cancer cells
New druggable DNA repair target to destroy cancer cells
Lung cancer patients with high EGFR expression live longer with cetuximab treatment
Lung cancer patients with high EGFR expression live longer with cetuximab treatment
Pemetrexed receives EC approval as a continuation maintenance therapy for NSCLC
Pemetrexed receives EC approval as a continuation maintenance therapy for NSCLC
<1...250251252253254...322>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top